Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afrezza Time in Range Study in T2DM
NCT04125082Phase 4Unknown
- Sponsor
- Diabetes & Glandular Disease Clinic
- Start
- Feb 2019
- Primary completion
- Mar 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of TI-Inhalation Powder B in type 2 diabetes mellitus (T2DM), sponsored by Diabetes & Glandular Disease Clinic. Status: unknown.
02
Drugs
TI-Inhalation Powder B
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04125082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04125082.